BRPI0416285A - beta-lactams para o tratamento de distúrbios do snc - Google Patents
beta-lactams para o tratamento de distúrbios do sncInfo
- Publication number
- BRPI0416285A BRPI0416285A BRPI0416285-4A BRPI0416285A BRPI0416285A BR PI0416285 A BRPI0416285 A BR PI0416285A BR PI0416285 A BRPI0416285 A BR PI0416285A BR PI0416285 A BRPI0416285 A BR PI0416285A
- Authority
- BR
- Brazil
- Prior art keywords
- alkyl
- cyano
- hydroxy
- halogen
- hydrogen
- Prior art date
Links
- 150000003952 β-lactams Chemical class 0.000 title abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 6
- 239000001257 hydrogen Substances 0.000 abstract 6
- 125000000217 alkyl group Chemical group 0.000 abstract 4
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 4
- 229910052736 halogen Inorganic materials 0.000 abstract 4
- 150000002367 halogens Chemical group 0.000 abstract 4
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 3
- 150000002431 hydrogen Chemical group 0.000 abstract 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 3
- 125000006272 (C3-C7) cycloalkyl group Chemical group 0.000 abstract 2
- 125000003545 alkoxy group Chemical group 0.000 abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 abstract 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 2
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 abstract 1
- 125000006570 (C5-C6) heteroaryl group Chemical group 0.000 abstract 1
- 108010078791 Carrier Proteins Proteins 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 102000003141 Tachykinin Human genes 0.000 abstract 1
- 125000002618 bicyclic heterocycle group Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- -1 cyano, hydroxy Chemical group 0.000 abstract 1
- 230000005764 inhibitory process Effects 0.000 abstract 1
- 230000001404 mediated effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 125000001624 naphthyl group Chemical group 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 230000000697 serotonin reuptake Effects 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
- 108060008037 tachykinin Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Addiction (AREA)
- Anesthesiology (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Hydrogenated Pyridines (AREA)
Abstract
"BETA-LACTAMS PARA O TRATAMENTO DE DISTúRBIOS DO SNC". A presente invenção relaciona-se aos novos compostos de fórmula (I), na qual ---- representa uma ligação simples ou uma dupla; R representa um radical selecionado a partir das fórmulas i) ii) iii) e iv) , nas quais R~ 1~ é halogênio, ciano, alquila de C~ 1-4~, alcóxi de C~ 1-4~, trifluormetila ou trifluormetóxi e p é zero ou um número inteiro de 1 a 3; R~ 2~ representa hidrogênio ou alquila de C~ 1-4~; R~ 3~ representa hidrogênio, hidróxi ou alquila de C~ 1-4~; R~ 4~ representa hidrogênio ou R~ 4~ juntamente com R~ 3~ representa =O ou =CH~ 2~; R~ 5~ representa fenila, naftila, um grupo heterocíclico bicíclico fundido de 9 a 10 elementos ou um grupo heteroarila de 5 ou 6 elementos, em que os ditos grupos são opcionalmente substituídos por 1 a 3 grupos independentemente selecionados a partir de trifluormetila, alquila de C~ 1-4~, hidróxi, ciano, alcóxi de C~ 1-4~, trifluormetóxi, halogênio ou S (O) q alquila de C~ 1-4~; R~ 6~ e R~ 7~ independentemente representam hidrogênio, ciano, alquila de C~ 1-4~; R~ 8~ é (CH~ 2~) rR~ 10~; R~ 9~ representa hidrogênio, halogênio, cicloalquila de C~ 3-7~, hidróxi, nitro, ciano ou alquila de C~ 1-4~ opcionalmente substituída por um ou dois grupos selecionados a partir de halogênio, ciano, hidróxi ou alcóxi de C~ 1-4~; R~ 10~ representa hidrogênio ou cicloalquila de C~ 3-7~; n representa 1 ou 2; q é 0, 1 ou 2; r é 0 ou um número inteiro de 1 a 4; ou um sal farmaceuticamente aceitável ou um solvato dos mesmos, ao processo para a sua preparação e ao seu uso no tratamento de condições mediadas por taquicininas e/ou por inibição seletiva da proteína transportadora de recaptação de serotonina.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0326407.4A GB0326407D0 (en) | 2003-11-12 | 2003-11-12 | Chemical compounds |
| PCT/EP2004/012772 WO2005049600A1 (en) | 2003-11-12 | 2004-11-10 | Beta-lactams for treatment of cns disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0416285A true BRPI0416285A (pt) | 2007-01-23 |
Family
ID=29726427
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0416285-4A BRPI0416285A (pt) | 2003-11-12 | 2004-11-10 | beta-lactams para o tratamento de distúrbios do snc |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US20080262041A1 (pt) |
| EP (1) | EP1689737B1 (pt) |
| JP (1) | JP2007510692A (pt) |
| KR (1) | KR20060118477A (pt) |
| CN (1) | CN1878764A (pt) |
| AR (1) | AR046233A1 (pt) |
| AT (1) | ATE401321T1 (pt) |
| AU (1) | AU2004291296B2 (pt) |
| BR (1) | BRPI0416285A (pt) |
| CA (1) | CA2546007A1 (pt) |
| CY (1) | CY1108404T1 (pt) |
| DE (1) | DE602004015144D1 (pt) |
| DK (1) | DK1689737T3 (pt) |
| ES (1) | ES2310295T3 (pt) |
| GB (1) | GB0326407D0 (pt) |
| HR (1) | HRP20080501T3 (pt) |
| IL (1) | IL175279A0 (pt) |
| IS (1) | IS8477A (pt) |
| MA (1) | MA28156A1 (pt) |
| MY (1) | MY138378A (pt) |
| NO (1) | NO20062661L (pt) |
| PL (1) | PL1689737T3 (pt) |
| PT (1) | PT1689737E (pt) |
| RU (1) | RU2006120417A (pt) |
| SI (1) | SI1689737T1 (pt) |
| TW (1) | TW200528439A (pt) |
| WO (1) | WO2005049600A1 (pt) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2015200142B2 (en) * | 2006-01-24 | 2016-07-07 | Unilever Plc | Novel lactams |
| AU2007209757A1 (en) * | 2006-01-24 | 2007-08-02 | Unilever Plc | Novel lactams |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL130088C (pt) * | 1960-03-14 | |||
| FR2676055B1 (fr) * | 1991-05-03 | 1993-09-03 | Sanofi Elf | Composes polycycliques amines et leurs enantiomeres, procede pour leur preparation et compositions pharmaceutiques les contenant. |
| CA2083891A1 (en) * | 1991-12-03 | 1993-06-04 | Angus Murray Macleod | Heterocyclic compounds, compositions containing them and their use in therapy |
| GB9200535D0 (en) * | 1992-01-10 | 1992-02-26 | Fujisawa Pharmaceutical Co | New compound |
| US5824690A (en) * | 1993-05-06 | 1998-10-20 | Hoechst Marion Roussel Inc. | Substituted pyrrolidin-3-yl-alkyl-piperidines |
| GB9317104D0 (en) * | 1993-08-17 | 1993-09-29 | Zeneca Ltd | Therapeutic heterocycles |
| GB9322643D0 (en) * | 1993-11-03 | 1993-12-22 | Zeneca Ltd | Lactam derivatives |
| DE69508093T2 (de) * | 1994-08-25 | 1999-07-15 | Merrell Pharmaceuticals Inc., Cincinnati, Ohio | Substituierte piperidine für die behandlung von allergischen krankheiten |
| US5780466A (en) * | 1995-01-30 | 1998-07-14 | Sanofi | Substituted heterocyclic compounds method of preparing them and pharmaceutical compositions in which they are present |
| TW332201B (en) * | 1995-04-06 | 1998-05-21 | Janssen Pharmaceutica Nv | 1,3-Dihydro-1-(phenylalkyl)-2H-imidazol-2-one derivatives |
| US6211199B1 (en) * | 1995-11-17 | 2001-04-03 | Aventis Pharmaceuticals Inc. | Substituted 4-(1H-benzimidazol-2-yl-amino)piperidines useful for the treatment of allergic diseases |
| FR2779429B1 (fr) * | 1998-06-03 | 2000-07-13 | Synthelabo | Derives d'oxindole, leurs preparations et leurs applications en therapeutique |
| US6204265B1 (en) * | 1998-12-23 | 2001-03-20 | Schering Corporation | Substituted oximes and hydrazones as neurokinin antagonists |
| GB0114867D0 (en) * | 2001-06-18 | 2001-08-08 | Merck Sharp & Dohme | Therapeutic agents |
| GB0412865D0 (en) * | 2004-06-09 | 2004-07-14 | Glaxo Group Ltd | Chemical compounds |
-
2003
- 2003-11-12 GB GBGB0326407.4A patent/GB0326407D0/en not_active Ceased
-
2004
- 2004-11-10 BR BRPI0416285-4A patent/BRPI0416285A/pt not_active IP Right Cessation
- 2004-11-10 HR HR20080501T patent/HRP20080501T3/xx unknown
- 2004-11-10 DK DK04797809T patent/DK1689737T3/da active
- 2004-11-10 SI SI200430872T patent/SI1689737T1/sl unknown
- 2004-11-10 AT AT04797809T patent/ATE401321T1/de active
- 2004-11-10 AR ARP040104145A patent/AR046233A1/es not_active Application Discontinuation
- 2004-11-10 DE DE602004015144T patent/DE602004015144D1/de not_active Expired - Lifetime
- 2004-11-10 TW TW093134192A patent/TW200528439A/zh unknown
- 2004-11-10 PL PL04797809T patent/PL1689737T3/pl unknown
- 2004-11-10 ES ES04797809T patent/ES2310295T3/es not_active Expired - Lifetime
- 2004-11-10 RU RU2006120417/04A patent/RU2006120417A/ru not_active Application Discontinuation
- 2004-11-10 US US10/595,662 patent/US20080262041A1/en not_active Abandoned
- 2004-11-10 KR KR1020067009274A patent/KR20060118477A/ko not_active Abandoned
- 2004-11-10 CN CNA2004800333979A patent/CN1878764A/zh active Pending
- 2004-11-10 CA CA002546007A patent/CA2546007A1/en not_active Abandoned
- 2004-11-10 PT PT04797809T patent/PT1689737E/pt unknown
- 2004-11-10 MY MYPI20044708A patent/MY138378A/en unknown
- 2004-11-10 EP EP04797809A patent/EP1689737B1/en not_active Expired - Lifetime
- 2004-11-10 AU AU2004291296A patent/AU2004291296B2/en not_active Ceased
- 2004-11-10 JP JP2006538791A patent/JP2007510692A/ja active Pending
- 2004-11-10 WO PCT/EP2004/012772 patent/WO2005049600A1/en not_active Ceased
-
2006
- 2006-04-27 IL IL175279A patent/IL175279A0/en unknown
- 2006-05-11 MA MA29020A patent/MA28156A1/fr unknown
- 2006-05-22 IS IS8477A patent/IS8477A/is unknown
- 2006-06-09 NO NO20062661A patent/NO20062661L/no not_active Application Discontinuation
-
2008
- 2008-10-08 CY CY20081101120T patent/CY1108404T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL175279A0 (en) | 2006-09-05 |
| HK1094698A1 (en) | 2007-04-04 |
| WO2005049600A1 (en) | 2005-06-02 |
| NO20062661L (no) | 2006-06-09 |
| US20080262041A1 (en) | 2008-10-23 |
| ATE401321T1 (de) | 2008-08-15 |
| GB0326407D0 (en) | 2003-12-17 |
| RU2006120417A (ru) | 2007-12-27 |
| DE602004015144D1 (de) | 2008-08-28 |
| MA28156A1 (fr) | 2006-09-01 |
| PL1689737T3 (pl) | 2008-12-31 |
| EP1689737B1 (en) | 2008-07-16 |
| DK1689737T3 (da) | 2008-10-27 |
| MY138378A (en) | 2009-05-29 |
| SI1689737T1 (sl) | 2008-12-31 |
| PT1689737E (pt) | 2008-10-24 |
| EP1689737A1 (en) | 2006-08-16 |
| HRP20080501T3 (en) | 2008-11-30 |
| JP2007510692A (ja) | 2007-04-26 |
| CY1108404T1 (el) | 2014-02-12 |
| TW200528439A (en) | 2005-09-01 |
| AU2004291296B2 (en) | 2011-04-07 |
| CN1878764A (zh) | 2006-12-13 |
| AR046233A1 (es) | 2005-11-30 |
| KR20060118477A (ko) | 2006-11-23 |
| AU2004291296A1 (en) | 2005-06-02 |
| ES2310295T3 (es) | 2009-01-01 |
| IS8477A (is) | 2006-05-22 |
| CA2546007A1 (en) | 2005-06-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9914451A (pt) | Composto de oxazol, processo para sua preparação, composição farmacêutica compreendendo dito composto, uso da composição e métodos de tratamento | |
| EA200500342A1 (ru) | Гетероциклические замещённые пиперазины для лечения шизофрении | |
| BRPI0414450A (pt) | derivados de diazabicicloalcano substituìdos como ligandos nos receptores de alfa 7 acetilcolina nicotìnica | |
| KR960014121A (ko) | 아로일-피페리딘 유도체 | |
| BR0201697A (pt) | Compostos de alfa-aminoácid0, processo para a sua preparação e composições farmacêuticas contendo os mesmos | |
| BR9912109A (pt) | Compostos, composições farmacêuticas, processo para a manufatura de um composto, e, método de tratar um mamìfero sofrendo de inflamação patológica e autoimunidade | |
| BR9914696A (pt) | Composto, processo para tratamento de distúrbio mediado por ciclo-oxigenase-2 em um indivìduo, e, composição farmacêutica | |
| ATE108774T1 (de) | Isoindolonderivate, ihre herstellung und ihre verwendung als zwischenprodukte zur herstellung von substanz-p-antagonisten. | |
| BR0205602A (pt) | EnantiÈmero possuindo a configuração s na posição-4 dos seu anel pirazol de um composto, composição farmacêutica, método para a preparação de composições farmacêuticas, processo para a preparação de compostos, e, métodos de tratamento de distúrbios que envolvem neurotransmissão canabinóide | |
| BR0109457A (pt) | Composto, composição farmacêutica,método de preparação de composições farmacêuticas, processo para prepapação de compostos, e, métodos de tratamento de distúrbios psiquiátricos, de distúrbios gastrointestinais e de distúrbios cardiovasculares | |
| BRPI0416004A (pt) | composto ou um sal, pró-droga ou solvato do mesmo, composição farmacêutica, método para o tratamento de doenças mediadas por glk, uso de um composto ou um sal, solvato ou pró-droga do mesmo, métodos para o tratamento combinado de obesidade e diabetes e para o tratamento de obesidade, e, processo para a preparação de um composto ou um sal, pró-droga ou solvato do mesmo | |
| BR0110112A (pt) | Derivados de pirrolidina e piperidina e seu uso para o tratamento de distúrbios neurodegenerativos | |
| EA200200912A1 (ru) | Новые производные индолин-2-она, их получение и их применение в качестве лигандов рецепторов окситоцина | |
| BR0011738A (pt) | Derivados de benzeno, processo para a preparação dos mesmos e composições farmacêuticas que os contêm | |
| UY26048A1 (es) | Derivados de piridopiranoacepinas, su preparacion y su aplicacion terapeutica | |
| BR0215200A (pt) | Pirrolidina-2-onas como inibidores de fator xa | |
| BRPI0409739A (pt) | composto, composição farmacêutica, uso de composto, e, método para o tratamento de uma doença ou de um distúrbio | |
| BRPI0406500A (pt) | processo farmacêutico e compostos preparados pelo mesmo | |
| BR9916669A (pt) | Uso de derivados de ácidos 4-biarilbutìricos e 5-biarilpentanóicos substituìdos como inibidores de metaloproteases de matriz para o tratamento de doenças respiratórias | |
| SE8107387L (sv) | Nya fenylalkylaminer, framstellning derav och anvendning som lekemedel | |
| BRPI0416285A (pt) | beta-lactams para o tratamento de distúrbios do snc | |
| BRPI0413791A (pt) | composto, método para o tratamento de um indivìduo humano ou animal que sofre de, ou que é suscetìvel a um distúrbio auto-imune ou uma condição inflamatória, uso de um composto, composição farmacêutica, e, processo para a prearação de compostos | |
| BR9907497A (pt) | Compostos de imidazolina, um processo para seu preparo e compostos farmacêuticos contendo os mesmos | |
| BRPI0410154A (pt) | derivados de amina cìclica, processos para preparação destes e composições farmacêuticas que os contêm | |
| SE0101978D0 (sv) | New compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 9A ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2260 DE 29/04/2014. |